Related Experiment Videos
Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta
Anita B Roberts1, Angelo Russo, Angelina Felici
1Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20895-5055, USA. robertsa@dce41.nci.nih.gov
Annals of the New York Academy of Sciences
|June 20, 2003
Summary
Smad3 signaling is crucial for wound healing and preventing fibrosis. Its absence impairs skin repair and promotes fibrotic disease, highlighting its importance in TGF-beta pathways.
Area of Science:
- Cellular biology
- Molecular biology
- Dermatology
Background:
- Transforming growth factor-beta (TGF-beta) is a key regulator of physiological and disease processes.
- TGF-beta signals through receptor kinases, activating Smad proteins to modulate gene transcription.
- Smad3 is one of two homologous proteins involved in TGF-beta/activin signaling.
Purpose of the Study:
- To investigate the function of Smad3 in TGF-beta signaling pathways.
- To understand the role of Smad3 in wound healing and fibrotic diseases.
Main Methods:
- Utilized genetically modified mice with a targeted deletion of the Smad3 gene.
- Assessed parameters of cutaneous wound healing, including reepithelialization and inflammatory cell influx.
- Modeled radiation-induced skin fibrosis in mice.
Main Results:
- Absence of Smad3 significantly impacted wound healing parameters.
- Smad3 deletion affected reepithelialization and inflammatory cell infiltration in cutaneous wounds.
- Smad3 deficiency influenced radiation-induced skin fibrosis in mice, suggesting a critical role in fibrotic processes.
Conclusions:
- Signaling through Smad3 is critical for TGF-beta's chemotactic activity.
- Smad3 is essential for TGF-beta's inhibitory effects on keratinocyte proliferation and migration.
- Smad3 plays a vital role in fibroblast chemoattraction and extracellular matrix elaboration in fibrotic diseases.